Holdings of AlphaCentric Life Sciences and Healthcare Fund
MUTUAL FUND SERIES TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 39.3M $ including 36.3M $ in equities, 92.4 %
- Positions
- 61 in 11 countries
- Top ten
- 41.8 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 20,260 | 2.8M $ | 7.18 % |
| 2 | AstraZeneca PLC | 11,232 | 2.2M $ | 5.63 % |
| 3 | Vertex Pharmaceuticals Inc | 4,931 | 2.2M $ | 5.60 % |
| 4 | Ionis Pharmaceuticals Inc | 19,587 | 1.5M $ | 3.74 % |
| 5 | Insmed Inc | 8,583 | 1.4M $ | 3.57 % |
| 6 | Incyte Corp | 14,245 | 1.3M $ | 3.41 % |
| 7 | Roivant Sciences Ltd | 47,667 | 1.3M $ | 3.36 % |
| 8 | Argenx SE | 1,794 | 1.3M $ | 3.33 % |
| 9 | Neurocrine Biosciences Inc | 9,607 | 1.3M $ | 3.22 % |
| 10 | Axsome Therapeutics Inc | 6,438 | 1.1M $ | 2.77 % |
| 11 | Ascendis Pharma A/S | 4,526 | 1M $ | 2.63 % |
| 12 | Apogee Therapeutics Inc | 11,369 | 956.9K $ | 2.43 % |
| 13 | Protagonist Therapeutics Inc | 9,040 | 952.8K $ | 2.42 % |
| 14 | Amgen Inc | 2,329 | 819.5K $ | 2.08 % |
| 15 | Rhythm Pharmaceuticals Inc | 9,297 | 808.6K $ | 2.06 % |
| 16 | AbbVie Inc | 3,544 | 770.8K $ | 1.96 % |
| 17 | Biogen Inc | 3,835 | 703.1K $ | 1.79 % |
| 18 | Sanofi SA | 14,382 | 692.9K $ | 1.76 % |
| 19 | Jazz Pharmaceuticals PLC | 3,561 | 673.2K $ | 1.71 % |
| 20 | Catalyst Pharmaceuticals Inc | 23,286 | 576.6K $ | 1.47 % |
| 21 | Oruka Therapeutics Inc | 11,506 | 564.4K $ | 1.44 % |
| 22 | BioNTech SE | 5,616 | 499.2K $ | 1.27 % |
| 23 | Krystal Biotech Inc | 1,918 | 495.5K $ | 1.26 % |
| 24 | Edgewise Therapeutics Inc | 15,615 | 491.9K $ | 1.25 % |
| 25 | Nuvalent Inc | 4,657 | 477.1K $ | 1.21 % |
| 26 | Agios Pharmaceuticals Inc | 13,971 | 472.6K $ | 1.20 % |
| 27 | Newamsterdam Pharma Co NV | 14,656 | 469.1K $ | 1.19 % |
| 28 | MeiraGTx Holdings plc | 53,694 | 465K $ | 1.18 % |
| 29 | Alnylam Pharmaceuticals Inc | 1,370 | 453.3K $ | 1.15 % |
| 30 | Kymera Therapeutics Inc | 5,342 | 444.9K $ | 1.13 % |
| 31 | Personalis Inc | 64,032 | 407.9K $ | 1.04 % |
| 32 | Celldex Therapeutics Inc | 12,614 | 400.1K $ | 1.02 % |
| 33 | Nurix Therapeutics Inc | 25,571 | 396.4K $ | 1.01 % |
| 34 | Abivax SA | 3,424 | 381.3K $ | 0.97 % |
| 35 | Cytokinetics Inc | 5,616 | 370.2K $ | 0.94 % |
| 36 | Spyre Therapeutics Inc | 6,634 | 334.6K $ | 0.85 % |
| 37 | Halozyme Therapeutics Inc | 4,794 | 309.8K $ | 0.79 % |
| 38 | Cullinan Therapeutics Inc | 20,135 | 286.1K $ | 0.73 % |
| 39 | Trevi Therapeutics Inc | 23,970 | 286K $ | 0.73 % |
| 40 | Natera Inc | 1,370 | 274K $ | 0.70 % |
| 41 | Xeris Biopharma Holdings Inc | 45,886 | 266.1K $ | 0.68 % |
| 42 | Disc Medicine Inc | 3,972 | 254K $ | 0.65 % |
| 43 | Design Therapeutics Inc | 21,231 | 225.9K $ | 0.57 % |
| 44 | Veracyte Inc | 6,838 | 220.3K $ | 0.56 % |
| 45 | Rezolute Inc | 71,227 | 217.2K $ | 0.55 % |
| 46 | Tectonic Therapeutic Inc | 6,849 | 211.7K $ | 0.54 % |
| 47 | WaVe Life Sciences Ltd | 29,175 | 211.5K $ | 0.54 % |
| 48 | Monte Rosa Therapeutics Inc | 12,566 | 206.7K $ | 0.53 % |
| 49 | Rapport Therapeutics Inc | 6,438 | 201.4K $ | 0.51 % |
| 50 | Sionna Therapeutics Inc | 4,818 | 193.2K $ | 0.49 % |
| 51 | Candel Therapeutics Inc | 36,313 | 177.9K $ | 0.45 % |
| 52 | Atrium Therapeutics Inc | 13,286 | 177.6K $ | 0.45 % |
| 53 | AVALO THERAPEUTICS INC | 11,668 | 174.2K $ | 0.44 % |
| 54 | Intellia Therapeutics Inc | 11,506 | 147.5K $ | 0.38 % |
| 55 | IQVIA Holdings Inc | 822 | 140.2K $ | 0.36 % |
| 56 | Arvinas Inc | 13,150 | 139.4K $ | 0.35 % |
| 57 | Annexon Inc | 24,518 | 135.8K $ | 0.35 % |
| 58 | ICON PLC | 973 | 107.7K $ | 0.27 % |
| 59 | ADMA Biologics Inc | 10,037 | 90.4K $ | 0.23 % |
| 60 | MDxHealth SA | 32,951 | 75.8K $ | 0.19 % |
| 61 | Aldeyra Therapeutics Inc | 37,120 | 62.7K $ | 0.16 % |
Sector breakdown
- Health care 45.7 %
- Unattributed 54.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 74.0 %
- United Kingdom 6.1 %
- Netherlands 4.9 %
- Bermuda 3.6 %
- France 3.0 %
- Denmark 2.8 %
- Ireland 2.1 %
- Germany 1.4 %
- Cayman Islands 1.3 %
- Singapore 0.6 %
- Belgium 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 48 | 26.9M $ | 73.98 % |
| 2 | United Kingdom | 1 | 2.2M $ | 6.09 % |
| 3 | Netherlands | 2 | 1.8M $ | 4.90 % |
| 4 | Bermuda | 1 | 1.3M $ | 3.63 % |
| 5 | France | 2 | 1.1M $ | 2.96 % |
| 6 | Denmark | 1 | 1M $ | 2.85 % |
| 7 | Ireland | 2 | 780.9K $ | 2.15 % |
| 8 | Germany | 1 | 499.2K $ | 1.37 % |
| 9 | Cayman Islands | 1 | 465K $ | 1.28 % |
| 10 | Singapore | 1 | 211.5K $ | 0.58 % |
| 11 | Belgium | 1 | 75.8K $ | 0.21 % |
Cite this page
Titelia. "Holdings of AlphaCentric Life Sciences and Healthcare Fund". https://titelia.com/en/funds/S000067055